Korro Bio, Inc. (KRRO)

USD 44.46

(-10.65%)

Market Cap (In USD)

416.51 Million

Revenue (In USD)

-

Net Income (In USD)

-81.17 Million

Avg. Volume

81.32 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
30.005-98.0
PE
-
EPS
-
Beta Value
0.0
ISIN
US5009461089
CUSIP
500946108
CIK
1703647
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Ram Aiyar MBA, Ph.D.
Employee Count
-
Website
https://www.korrobio.com
Ipo Date
2019-10-03
Details
Korro Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases. Korro Bio, Inc. is based in Cambridge, Massachusetts.